Azithromycin
Jump to navigation
Jump to search
In medicine, azithromycin is a "semi-synthetic macrolide antibiotic structurally related to erythromycin. It has been used in the treatment of Mycobacterium avium intracellular infections, toxoplasmosis, and cryptosporidiosis."[1]
Development
Azithromycin was patented in 1982.[2] Zithromax was approved by the Food and Drug Administration for Pfizer in 1991.[3] Non-authorized generic drugs manufactured by Teva, Sandoz, and Abraxis were approved in the United States starting in 2005.[3]
Drug toxicity
Drug toxicity includes cardiovascular death.[4]
References
- ↑ Anonymous (2024), Azithromycin (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ patent:4328334 - Google Patents. Retrieved on 2009-02-01.
- ↑ 3.0 3.1 Drugs@FDA. Food and Drug Administration. Retrieved on 2009-02-01. Cite error: Invalid
<ref>tag; name "urlDrugs@FDA" defined multiple times with different content - ↑ Ray et al. (2012) Azithromycin and the Risk of Cardiovascular Death